Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Gametocyte-specific factor 1 (GTSF1) is a highly conserved protein of 167 amino acids containing two CHHC-type zinc-finger domains, primarily expressed in germ cells, and essential for their development and maintenance. GTSF1 acts as a co-factor in the piRNA pathway by binding to PIWI proteins, ensuring efficient silencing of genomic transposable elements and maintenance of DNA integrity in germline cells. In mammals, loss of GTSF1 function leads to defective piRNA biogenesis, derepression of retrotransposons, and infertility due to germ cell loss and meiotic arrest. In certain cancers, altered expression of GTSF1 has been observed, indicating potential utility as a biomarker. Though crucial to fertility and genome integrity, GTSF1 is not currently targeted by any approved drugs, and its molecular role is predominantly regulatory rather than enzymatic or signal transductive.
Binds PIWI proteins, enhances piRNA biogenesis, mediates silencing of retrotransposons through chromatin modification and RNA cleavage. In some species, drives assembly of RNA-dependent silencing complexes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gametocyte-specific factor 1 (GTSF1).